Inclinical and Arable Agree to Promote e-Clinical Software Solutions

Inclinical brings innovative CTMS and EDC software to clinical organizations without the traditionally high start-up costs associated with traditional systems.

Integrated Clinical Solutions, Inc. (Inclinical) has partnered with Arable Corporation (Arable) to bring Inclinical's innovative CTMS and EDC software, Inclinical Perform, to the global clinical trial industry. The OEM branded "Arable Perform" will be available to Arable's global client base with strong presence in India, the US and several emerging pharmaceutical research markets.

Inclinical's President, J Peter Armerding, stated "We are proud to offer our Perform product through Arable Corporation. Inclinical creates software exclusively for clinical operations to reduce the redundant work historically required by clinical staff. When you combine the industry knowledge and global marketing scope of Arable with Inclinical's Perform technology, you have a winning solution."

Traditional CTMS systems have been costly and required months to implement. Perform brings CTMS and EDC capabilities without the traditionally high start up costs. With Perform's real-time dashboard, stakeholders and managers are able to view real-time status of trials down to the site or subject visit activity.

The Perform platform allows Sponsors or CROs to manage the planning and implementation of multiple trials simultaneously. Additionally, Perform provides large Sites with the ability to manage their service delivery to multiple CROs or Sponsors.

"Our new Arable Perform platform allows us to offer our clients immediate access to clinical trial software with the shortest 'Go Live' time in the industry and at reasonable cost," stated Manpreet S Rana, Vice President Corporate Affairs Asia Pacific, of Arable Corporation.

Integrated Clinical Solutions, Inc. (www.inclinical.com) creates software exclusively for clinical trial organizations. We build collaborative software products to help automate clinical operations in the pharmaceutical, biotechnology and medical device industries. Our software is designed to be implemented quickly and easily understood by clinical operations end users. For inquires into Inclinical's trial operations software contact Kelly Noseworthy kelly(at)inclinical(dot)com.

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.